Medtronic: FY26 Outlook Strengthened By New Product Launches

Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating.
MedTech Dive

Medtronic expands AI, robotics hub in London; Virtuoso robot gets FDA breakthrough status

The Medtronic center will facilitate surgeon collaboration and AI-powered decision support. At Virtuoso Surgical, a robotic ...
Bloomberg L.P.

Medtronic Expands Board After Elliott Buys Stake, Outlook Raised

Medtronic Plc will expand its board after Elliott Investment Management became one of its biggest investors. The medical device maker also reported profit that beat estimates and lifted full-year ...
Reuters

Medtronic to add two new directors after Elliott takes large stake

Elliott Investment Management L.p. Aug 19 (Reuters) - Medtronic (MDT.N), opens new tab said on Tuesday it would add two new directors to its board and set up committees to help boost its lagging ...